Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
- Latest News
- Most Popular
- 3 Top-Ranked Consumer ETFs to Buy Now
- This Week's Top Value Stocks
- RTI: When Will We Finally See a Pullback?
- RTI: When is the Fed's "Taper Telegraph" Coming?
- Insurance Industry Stock Outlook - May 2013
- Top Stocks with Big Potential Catch-Up Moves
- Roundtable Top Picks of the Week
- Anatomy of Success: Green Mountain Coffee
- The Mega-Rally Rolls On
- Biotechnology ETF Investing 101
- AWS 5/21: The Beginning of the End for QE
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 05/21/2013
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Compuware Corporation ( CPWR - Analyst Report ) reported earnings per share of 5 cents in the second quarter of fiscal 2013, compared to 10 cents in the year-ago quarter and 5 cents in the previous quarter. Net income came in at $10.6 million versus $22.7 million in the previous year quarter and $10.5 million in the last quarter.
The earnings in the reported quarter missed the Zacks Consensus Estimate of 6 cents per share.
Revenues
Total revenue for the quarter came in at $220.6 million, declining 15.4% year over year and 2.5% sequentially.
Software license fees came in at $31.7 million, down 48.7% year over year. Maintenance fees were $102.2 million, down 6.3% annually. Subscription fees amounted to $20.2 million, up nearly 6% from the prior year quarter.
Professional services fees were nearly $46 million, down 13.7% from the previous year period. Application services fees increased 17.1% year over year to $20.5 million.
Margins
Operating income totaled $17.2 million, falling approximately by 55% from the previous year quarter. Operating margin declined to 7.8% from 14.6% in the previous year quarter but increased from 7.3% in the previous quarter.
Administrative and general expenses amounted to $38.4 million compared with $42 million in the previous year quarter.
Balance Sheet and Cash Flow
Exiting second quarter of fiscal 2013, cash and cash equivalents amounted to $63.5 million declining from $83.5 million in the last quarter. Long-term debt increased to $59.3 million from $36.5 million at the end of the previous quarter.
Cash flow from operations for the first six months of fiscal 2013 came in at $16.3 million versus $31.8 million in the previous year period.
Guidance
The company reduced its revenue guidance from $1.04 billion to $1.05 billion to $980 million to $995 million for fiscal 2013 along with earnings per share of 36 cents – 40 cents from 43 cents – 47 cents.
The company projects that the cash flow from operations will be within the range of $150 million -$160 million.
The company currently retains a Zacks #3 Rank, which translates into a short-term ‘Hold’ rating. However, we presently maintain our ‘Neutral’ recommendation on the stock.
Read the full reports :
Analyst Report on CPWR